Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TollB-001 in Moderate to Severe Active Rheumatoid Arthritis
NCT07408024Phase 2Recruiting
- Sponsor
- Toll Biotech Co., Ltd.
- Start
- Sep 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tollb-001 in rheumatoid arthritis (RA), sponsored by Toll Biotech Co., Ltd.. Started Sep 2025; status: recruiting.
02
Drugs
tollb-001
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT07408024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07408024.